ImmunityBio (IBRX) EBT (2014 - 2026)
ImmunityBio's (IBRX) quarterly EBT came in at -$632.8 million in Q1 2026, down 387.13% year-on-year from $220.4 million in Q1 2025, and down 919.1% on a QoQ basis from -$62.1 million in Q4 2025.
ImmunityBio (IBRX) EBT (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 13 years of EBT data on file, last reported at -$632.8 million in Q1 2026.
- On a quarterly basis, EBT fell 387.13% year-over-year to -$632.8 million in Q1 2026; TTM through Mar 2026 was -$854.5 million, a 108.71% decrease from a year earlier, with the FY2025 full-year figure at -$351.6 million, up 15.0% from the prior year.
- EBT for Q1 2026 stood at -$632.8 million, down from -$62.1 million in the prior quarter.
- Over the last five years, EBT for IBRX reached as high as -$59.2 million in Q4 2024 and fell as low as -$632.8 million in Q1 2026.
- Historically, EBT has averaged -$141.1 million across 5 years, with a median of -$108.3 million in 2022.
- Across the five-year window, EBT soared 74.65% in 2024 and tumbled 387.13% in 2026, its largest moves.
- Year by year, EBT stood at -$108.3 million in 2022, then sank by 115.58% to -$233.5 million in 2023, then surged by 74.65% to -$59.2 million in 2024, then retreated by 4.92% to -$62.1 million in 2025, then sank by 919.1% to -$632.8 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$632.8 million in Q1 2026, -$62.1 million in Q4 2025, and -$67.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn | -632.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -632.79 Mn |
| Dec 31, 2025 | -62.09 Mn |
| Sep 30, 2025 | -67.31 Mn |
| Jun 30, 2025 | -92.31 Mn |
| Mar 31, 2025 | -129.90 Mn |
| Dec 31, 2024 | -59.18 Mn |
| Sep 30, 2024 | -85.75 Mn |
| Jun 30, 2024 | -134.58 Mn |
| Mar 31, 2024 | -134.13 Mn |
| Dec 31, 2023 | -233.45 Mn |
| Sep 30, 2023 | -95.64 Mn |
| Jun 30, 2023 | -138.21 Mn |
| Mar 31, 2023 | -116.58 Mn |
| Dec 31, 2022 | -108.29 Mn |
| Sep 30, 2022 | -111.16 Mn |
| Jun 30, 2022 | -94.84 Mn |
| Mar 31, 2022 | -103.00 Mn |
| Dec 31, 2021 | -91.55 Mn |
| Sep 30, 2021 | -88.43 Mn |
| Jun 30, 2021 | -89.38 Mn |